Roxindole, a dopamine autoreceptor agonist with a potential antidepressant activity. II. Effects on the 5-hydroxytryptamine system

Pharmacopsychiatry

Volumn 30, Issue 2, 1997, Pages 55-61

  Maj, J ^a   Kolodziejczyk K ^a   Rogoz Z ^a   Skuza, G ^a  

^a POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; DOPAMINE RECEPTOR; FENFLURAMINE; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; PINDOLOL; ROXINDOLE; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; HYPOTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN SYNDROME; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030887133     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979483     Document Type: Article

References (26)

1. Arnt, J., J. Hyttel, J. J. Larsen: The citalopram/5-HTP-induced shake syndrome is correlated to 5-HT2 receptor affinity and also influenced by other transmitters. Acta Pharmacol. Toxicol. 55 (1984) 363-372
2. 2 autoreceptor agonist. J. Pharmacol. Exp. Ther. 276 (1996) 41-48
3. Benkert, O., G. Gründer, H. Wetzel: Dopamine autoreceptor agonists in the treatment of schizophrenia and major depression. Pharmacopsychiat. 25 (1992) 254-260
4. Benkert, O., F. Müller-Siecheneder, H. Wetzel: Dopamine agonists in schizophrenia: a review. Eur. Neuropsychopharmacol. Suppl. (1995) 43-53
5. Corne, S. J., R. W. Pickering, B. T. Warner: A method for assessing the effects of drugs on the central actions of 5-hydroxy-tryptamine. Br. J. Pharmacol. 20 (1963) 106-120
6. 1A receptors. Eur. J. Pharmacol. 237 (1993) 283-291
7. 1 function. Neuropharmacology 24 (1985) 1187-1194
8. Gründer, G., H. Wetzel, E. Hammes, O. Benkert: Roxindole, a dopamine autoreceptor agonist, in the treatment of major depression. Psychopharmacol. 111 (1993) 123-126
9. Hicks, P. B.: The effect of serotoninergic agents on haloperidol-induced catalepsy. Life Sci. 47 (1990) 1609-1615
10. Janssen, P. A. J., A. H. M. Jageneau, K. H. L.: Schellekens: Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone. Part IV. Influence of haloperidol (R 1625) and of chlorpromazine on the behaviour of rats in an unfamiliar "open field" situation. Psychopharmacologia 1 (1960) 389-392
11. 1C receptors. Br. J. Pharmacol. 94 (1988) 137-147
12. Klimke, A., E. Klieser: Antipsychotic efficacy of the dopaminergic autoreceptor agonist EMD 49980 (roxindol). Results of an open clinical study. Pharmacopsychiat. 24 (1991) 107-112
13. Kłodzińska, A., E. Chojnacka-Wójcik: Hyperthermia induced by m-trifluoromethylphenylpiperazine (TFMPP) or m-chlorophenylpiperazine (m-CPP) in heat adapted rats. Psychopharmacol. 109 (1992) 466-472
14. Kłodzińska, E., T. Jaros, E. Chojnacka-Wójcik, J. Maj: Exploratory hypoactivity induced by m-trifluoromethylphenylpiperazine (TFMPP) and m-chlorophenylpiperazine (m-CPP). J. Neural Transm. [P.-D.Sect] 1 (1989) 207-218
15. 1B receptors? J. Neural Transm. 73 (1988) 43-55
16. Maj, J., K. Kołodziejczyk, Z. Rogóż, G. Skuza: Roxindole, a potential antidepressant. I. Effect on the dopamine system. J. Neural Transm. 103 (1996) 627-641
17. Maj, J., J. Sarnek, V. Klimek, A. Rawłów: On the anticataleptic action of cyproheptadine. Pharmacol. Biochem. Behav. 5 (1976) 201-205
18. 1A autoreceptor function? In: Fozard, J. R., P. R. Saxena (eds.): Serotonin: molecular biology, receptors and functional effects. Birkhauser, Basel (1991) 483-490
19. Pawłowski, L.: Different action of 5-hydroxytryptamine (5-HT) uptake inhibitors on fenfluramine - but not p-chloroamphetamine-induced hyperthermia in rats. J. Pharm. Pharmacol. 33 (1981) 538-540
20. Przegaliński, E., M. Filip, B. Budziszewska, E. Chojnacka-Wójcik: Antagonism of (+)WAY 100135 to behavioral, hypothermie and corticosterone effects induced by 8-OH-DPAT. Pol. J. Pharmacol. 46 (1994) 21-27
21. Przegaliński, E., A. M. Ismaiel, E. Chojnacka-Wójcik, B. Budziszewska, E. Tatarczyńska, E. Błaszczyńska: The behavioural, but not the hypothermie or corticosterone, response to 8-hydroxy-2-(Di-n-propyloamino)-tetralin, is antagonized by NAN-190 in the rat. Neuropharmacology 29 (1990) 521-526
22. Seyfried, Ch. A., H. E. Greiner, A. F. Haase: Biochemical and functional studies on EMD 49980: a potent, selectively presynaptic D-2 dopamine agonist with actions on serotonin systems. Eur. J. Pharmacol. 160 (1989) 31-41
23. 2-receptor selectivity of roxindole (EMD 49980). Possible indirect effects on postsynaptic striatal cholinergic neurons. In: Advances in neuropsychiatry and psychopharmacology, Vol. 1 Schizophrenia Research, Raven Press Ltd., New York (1991) 317-322
24. Sulpizio, A., P. J. Fowler, E. Macko: Antagonism of fenfluramine-induced hyperthermia: a measure of central serotonin inhibition. Life Sci. 22 (1978) 1439-1446
25. 1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(Di-n-propylamino)tetralin in the rat. Eur. J. Pharmacol. 106 (1985) 271-282
26. Wetzel, H., O. Benkert: Dopamine autoreceptor agonists in the treatment of schizophrenic disorders. Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 17 (1993) 525-540